Bain Capital Public Equity Management’s PTC Therapeutics PTCT Stock Holding History

Bain Capital Public Equity Management’s Portfolio PTCT Stock Details PTCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-906,201	Closed	-$24.2M	–	37
2015 Q3	$24.2M	Sell	906,201 -132,154	-13%	-$5.65M	0.72%	32
2015 Q2	$50M	Sell	1,038,355 -612,980	-37%	-$35.8M	1.3%	27
2015 Q1	$100M	Sell	1,651,335 -430,597	-21%	-$26.3M	2.5%	17
2014 Q4	$108M	Sell	2,081,932 -780,093	-27%	-$34.3M	2.7%	14
2014 Q3	$126M	Hold	2,862,025	–	–	3.23%	9
2014 Q2	$74.8M	Hold	2,862,025	–	–	1.81%	21
2014 Q1	$74.8M	Buy	2,862,025 +444,490	+18%	+$11.9M	1.99%	22
2013 Q4	$41M	Buy	2,417,535 +84,202	+4%	+$1.48M	1.16%	34
2013 Q3	$50.1M	Buy	+2,333,333	New	+$40.6M	1.26%	31

Other funds holding PTCT

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Bain Capital Public Equity Management's PTCT Position: Q4 2015 in Review

Bain Capital Public Equity Management sold out of PTC Therapeutics (PTCT) in Q4 2015, closing a stake of 906,201 shares — an estimated $24.2M sold.

Bain Capital Public Equity Management first reported a position in PTCT in Q3 2013 and held it in 9 quarters. The position peaked at $126M in Q3 2014. 141 funds tracked by Wall St. Rank hold PTCT as of Q4 2015.

Bain Capital Public Equity Management reported no remaining PTC Therapeutics position as of Q4 2015 after selling out during the quarter.
Bain Capital Public Equity Management sold 906,201 PTC Therapeutics shares in Q4 2015, an estimated $24.2M.
Bain Capital Public Equity Management first reported a position in PTC Therapeutics in Q3 2013 and held it in 9 quarters.
Bain Capital Public Equity Management's PTC Therapeutics position peaked at $126M in Q3 2014.
141 funds tracked by Wall St. Rank held PTC Therapeutics as of Q4 2015.

Based on Bain Capital Public Equity Management's 13F filing for Q4 2015, filed 16 Feb 2016.